Suppr超能文献

活性维生素 D、阿法骨化醇和低强度有氧运动对 2 型糖尿病模型大鼠骨质疏松和肌肉萎缩的影响。

Effects of activated vitamin D, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats.

机构信息

Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita City, Akita, Japan.

出版信息

PLoS One. 2018 Oct 17;13(10):e0204857. doi: 10.1371/journal.pone.0204857. eCollection 2018.

Abstract

Diabetes mellitus causes secondary osteoporosis and muscle atrophy. The ability of alfacalcidol (ALF) and exercise (Exe) to inhibit osteoporosis and muscle atrophy in type 2 diabetes mellitus (T2DM) model rats was examined. Twenty-week-old Otsuka Long-Evans Tokushima Fatty rats were randomized to ALF (orally 0.1 μg/kg/day), Exe (treadmill exercise at 10 m/min, 60 min/day, 5 days/week), Comb (ALF and Exe), and Cont (T2DM control treated with vehicle and no exercise) groups (n = 8-10 per group). Sedentary Long-Evans Tokushima Otsuka rats were used as a non-hyperphagic control. After treatment for 2 or 6 weeks, blood glucose (BG) levels, cross-sectional area (CSA) of tibialis anterior muscle fibers, femoral bone mineral density (BMD), and relative quantities of muscle anabolic markers (Pax7, MyoD, and myogenin) and catabolic markers (Atrogin-1, MuRF1, and REDD1) of the soleus muscle assessed by real-time polymerase chain reaction assays were measured. Exe and Comb treatments for 6 weeks decreased BG levels compared with those of the Cont group. ALF, Exe, and Comb treatments for 2 and 6 weeks recovered the CSA compared with that of the Cont group. ALF and Comb treatments for 6 weeks increased femoral BMDs compared with those of the Cont group. After 2 weeks of treatment, Comb treatment increased MyoD expression and decreased MuRF1 expression. ALF or Exe monotherapy significantly decreased Atrogin-1 or MuRF1 expression after 2 weeks of treatment, respectively. After 6 weeks of treatment, ALF and Comb treatments decreased Atrogin-1 and REDD1. These results demonstrate that a combination of ALF and Exe improved CSA from the early phase of treatment by stimulating skeletal muscle differentiation and suppressing muscle catabolic genes. Improvements in BG, BMD, and CSA were observed as long-term effects of the combination therapy. Continued suppression of muscle catabolic genes was observed as a background to these effects.

摘要

糖尿病会导致继发性骨质疏松症和肌肉萎缩。本研究旨在观察骨化三醇(ALF)和运动(Exe)对 2 型糖尿病(T2DM)模型大鼠骨质疏松症和肌肉萎缩的抑制作用。20 周龄的 Otsuka Long-Evans Tokushima Fatty 大鼠随机分为 ALF(口服 0.1μg/kg/天)、Exe(跑步机运动,速度 10m/min,每天 60 分钟,每周 5 天)、Comb(ALF 和 Exe)和 Cont(用载体和不运动治疗的 T2DM 对照)组(每组 8-10 只)。静止的 Long-Evans Tokushima Otsuka 大鼠被用作非高血糖对照。治疗 2 或 6 周后,通过实时聚合酶链反应测定,测量血糖(BG)水平、比目鱼肌纤维横截面积(CSA)、股骨骨密度(BMD)以及肌肉合成代谢标志物(Pax7、MyoD 和肌生成素)和 catabolic 标志物(Atrogin-1、MuRF1 和 REDD1)的相对数量。与 Cont 组相比,Exe 和 Comb 治疗 6 周可降低 BG 水平。ALF、Exe 和 Comb 治疗 2 和 6 周可恢复 CSA 与 Cont 组相比。与 Cont 组相比,ALF 和 Comb 治疗 6 周可增加股骨 BMD。治疗 2 周后,Comb 治疗增加了 MyoD 的表达并降低了 MuRF1 的表达。ALF 或 Exe 单药治疗分别在治疗 2 周后显著降低了 Atrogin-1 或 MuRF1 的表达。治疗 6 周后,ALF 和 Comb 治疗降低了 Atrogin-1 和 REDD1。这些结果表明,ALF 和 Exe 的联合治疗通过刺激骨骼肌分化和抑制肌肉分解代谢基因,从治疗早期改善 CSA。改善 BG、BMD 和 CSA 是联合治疗的长期效果。持续抑制肌肉分解代谢基因是这些效果的背景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef5/6192580/bebabf0a6cdb/pone.0204857.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验